In a report, the regulator sharply criticized pharmacy benefit managers, a reversal from its longstanding hands-off approach to policing the companies.
F.T.C. Says Middlemen Seem to Drive Up Drug Prices
Written by
in
Antitrust Laws and Competition Issues, CIGNA Corporation, CVS Caremark Corporation, Drugs (Pharmaceuticals), Drugstores, Express Scripts Inc, Federal Trade Commission, Health Insurance and Managed Care, Khan, Lina, pharmacy benefit managers, Prices (Fares, Fees and Rates), Regulation and Deregulation of Industry, United States Politics and Government, UnitedHealth Group Inc